Rotigotine and parkinsonism-hyperpyrexia syndrome
Shohei Watanabe, Ayano Hasuike, Hosho Morishita, Koji Yagi, Eiko Fujiwara, Daisuke Yamanaka, Shuhei Kasama, Masataka Igeta, Takashi Kimura · 2026
Read Rotigotine and parkinsonism-hyperpyrexia syndrome by Shohei Watanabe, Ayano Hasuike, Hosho Morishita, Koji Yagi, Eiko Fujiwara, Daisuke Yamanaka, Shuhei Kasama, Masataka Igeta, Takashi Kimura (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13157179.txt.
Description
Stopping Parkinson's drugs abruptly can trigger a dangerous fever syndrome, and Shohei Watanabe and co-authors asked whether a skin-patch drug guards against it. They reviewed one hundred forty-seven emergency admissions for the disease at one Japanese hospital over fourteen years. Thirty cases met the marks of the fever syndrome, and the team compared drugs and triggers between the groups.
Skipped doses were the commonest trigger, named in over a third of syndrome cases. The patch drug, rotigotine, which seeps steadily through the skin, turned up in fewer syndrome cases than expected. Careful adjustment showed a lean toward protection that just missed the usual mark of proof. The authors stress steady dosing first, while suggesting the patch when swallowing fails.
Catalog record
| CREATOR | Shohei Watanabe, Ayano Hasuike, Hosho Morishita, Koji Yagi, Eiko Fujiwara, Daisuke Yamanaka, Shuhei Kasama, Masataka Igeta, Takashi Kimura |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 19 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |